1231 Stock Overview
Engages in the research, development, production, and sale of pesticide preparation products in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Norsyn Crop Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.82 |
| 52 Week High | CN¥26.00 |
| 52 Week Low | CN¥10.86 |
| Beta | 0 |
| 1 Month Change | -12.31% |
| 3 Month Change | -7.84% |
| 1 Year Change | -33.12% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -16.60% |
Recent News & Updates
Shareholder Returns
| 1231 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | -0.3% | -0.8% | 0.06% |
| 1Y | -33.1% | -19.9% | -16.1% |
Return vs Industry: 001231 underperformed the CN Chemicals industry which returned -19.9% over the past year.
Return vs Market: 001231 underperformed the CN Market which returned -16.1% over the past year.
Price Volatility
| 1231 volatility | |
|---|---|
| 1231 Average Weekly Movement | 6.7% |
| Chemicals Industry Average Movement | 7.1% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.2% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 001231 has not had significant price volatility in the past 3 months.
Volatility Over Time: 001231's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 618 | Jingmin Zheng | www.norsyn.com |
Norsyn Crop Technology Co., Ltd. engages in the research, development, production, and sale of pesticide preparation products in China and internationally. It offers insecticides, fungicides, and herbicides, as well as plant growth regulator, plant nutrition, and seed coating agent products. Norsyn Crop Technology Co., Ltd.
Norsyn Crop Technology Co., Ltd. Fundamentals Summary
| 1231 fundamental statistics | |
|---|---|
| Market cap | CN¥1.47b |
| Earnings (TTM) | CN¥50.67m |
| Revenue (TTM) | CN¥594.83m |
29.1x
P/E Ratio2.5x
P/S RatioIs 1231 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1231 income statement (TTM) | |
|---|---|
| Revenue | CN¥594.83m |
| Cost of Revenue | CN¥400.40m |
| Gross Profit | CN¥194.43m |
| Other Expenses | CN¥143.76m |
| Earnings | CN¥50.67m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.51 |
| Gross Margin | 32.69% |
| Net Profit Margin | 8.52% |
| Debt/Equity Ratio | 11.7% |
How did 1231 perform over the long term?
See historical performance and comparison